Cough Management Wellness App for Refractory or Unexplained Chronic Cough
NCT07070895 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-09-11
Summary
The goal of this single-cohort clinical trial is to learn whether a smartphone-based Cough Management (CM) program can reduce cough frequency and burden in adults (21-80 years) who have refractory or unexplained chronic cough. 
The main questions it aims to answer are:
* Does four weeks of using the CM feature in the CoughPro app lower objective cough rate (coughs per hour) compared with each participant's one-week baseline? 
* Does the program also lessen cough intensity (bout metrics) and improve patient-reported quality-of-life scores on the Leicester Cough Questionnaire and PGI-S?
Participants will:
* Wear a Hyfe CoughMonitor smartwatch continuously for 6 weeks (1-week baseline, 4-week intervention, 1-week follow-up), charging it nightly. 
* Complete science-based in-app CM lessons based on behavioral cough-suppression therapy and practice the techniques during the 4-week intervention.
* Fill out online questionnaires (LCQ and PGI-S) at baseline and at the end of Week 4.
* Join a brief exit interview, then return the smartwatch and receive a compensation voucher.
Conditions
- Refractory Chronic Cough
- Unexplained Chronic Cough
- Cough Hypersensitivity
Interventions
- BEHAVIORAL
-
Cough Management
CoughPro is a smartphone wellness application that uses algorithms to detect and count coughs continuously and passively (similar to a "step counter," but for cough). CoughPro also includes a Cough Management (CM) component, which delivers short, structured behavioral lessons (based on BCST) designed to help users recognize their urge to cough and apply cough suppression strategies in real-world settings. The Cough Management wellness feature is the key area of investigation in this study. The novel CM program is delivered entirely through participants' devices. The application aims to help users better understand and manage their cough by coupling real-time cough detection with self-management BCST resources: * Reduce cough frequency (coughs per hour). * Reduce cough intensity (as measured by cough bouts). * Improve cough-related quality of life (as reported by patients and its correlation with cough-free time as measured objectively).
- DEVICE
-
CoughMonitor Suite
CoughMonitor Suite's smartwatch is used in this study to continuously, automatically, and passively monitor cough frequency in a fully privacy-preserving way - no audio is recorded, stored, or synced to the cloud, and no human is in the loop.
Sponsors & Collaborators
-
Hyfe Inc
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-27
- Primary Completion
- 2025-08-08
- Completion
- 2025-09-30
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)
NCT01432730 ·Status: COMPLETED ·Phase: PHASE2
-
ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis
NCT03638063 ·Status: UNKNOWN
-
GSK2339345 Hypertussive Challenge Study
NCT01899768 ·Status: COMPLETED ·Phase: PHASE2
-
An 8-Week Refractory Chronic Cough Study (MK-7264-021)
NCT02612623 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888)
NCT00506545 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough
NCT05392192 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012)
NCT02612610 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension
NCT04525885 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of S-600918 in Adults With Refractory Chronic Cough
NCT04110054 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough
NCT05660850 ·Status: COMPLETED ·Phase: PHASE2
-
A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough
NCT07288528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)
NCT02476890 ·Status: COMPLETED ·Phase: PHASE2
-
ATP and P2X3 Receptor in Chronic Cough
NCT05713019 ·Status: UNKNOWN ·Phase: NA
-
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)
NCT03449134 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Efficacy and Safety of AX-8 in Chronic Cough
NCT04866563 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough.
NCT01807832 ·Status: UNKNOWN ·Phase: NA
-
ATP Level and Cough Sensitivity to ATP in Subjects With Refractory/Unexplained Chronic Cough
NCT05265871 ·Status: COMPLETED
-
Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection
NCT01597349 ·Status: COMPLETED ·Phase: PHASE2
-
Lidocaine: Effect of Lidocaine in Chronic Cough
NCT01252225 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887)
NCT00506987 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)
NCT03449147 ·Status: COMPLETED ·Phase: PHASE3
-
Laryngeal Nerve Block for Chronic Cough
NCT05292677 ·Status: UNKNOWN ·Phase: PHASE4
-
A Comprehensive Evaluation of the Impact of ATP on Laryngeal Symptoms, Hypersensitivity and Function
NCT05570981 ·Status: UNKNOWN
-
Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)
NCT04901455 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough
NCT06504446 ·Status: RECRUITING ·Phase: PHASE2